E233-1917 Screening compound: 2-[(2-chlorophenyl)methyl]-N-(3,4-dimethoxyphenyl)-8-methyl-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide

E233-1917 Screening compound: 2-[(2-chlorophenyl)methyl]-N-(3,4-dimethoxyphenyl)-8-methyl-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide
E233-1917 Screening compound: 2-[(2-chlorophenyl)methyl]-N-(3,4-dimethoxyphenyl)-8-methyl-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E233-1917
2-[(2-chlorophenyl)methyl]-N-(3,4-dimethoxyphenyl)-8-methyl-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E233-1917

Molecular Formula

C26H24ClN3O4 (C26 H24 ClN3 O4)

Compound Name

2-[(2-chlorophenyl)methyl]-N-(3,4-dimethoxyphenyl)-8-methyl-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide

IUPAC name

2-[(2-chlorophenyl)methyl]-N-(34-dimethoxyphenyl)-8-methyl-2H4H5H-furo[23-g]indazole-7-carboxamide

SMILES

Cc1c(C(Nc(cc2)cc(OC)c2OC)=O)oc2c1-c1nn(Cc(cccc3)c3Cl)cc1CC2

InChI

InChI=1S/C26H24ClN3O4/c1-15-23-21(34-25(15)26(31)28-18-9-11-20(32-2)22(12-18)33-3)10-8-17-14-30(29-24(17)23)13-16-6-4-5-7-19(16)27/h4-7,9,11-12,14H,8,10,13H2,1-3H3,(H,28,31)

InChI Key

YKHIVOMLACQQCT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14850697

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

477.95

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.757

Distribution Coefficient, logD

4.757

Water Solubility, LogSw

-5.01

Polar Surface Area

62.188

Acid Dissociation Constant (pKa)

10.49

Base Dissociation Constant (pKb)

-0.82

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.10

E233-1917 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral Annotated Library (21441 compounds)

CNS targets activity set (6557 compounds)

Protein-Protein Interaction Library (218420 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Immune system
Mechanism of action:
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E233-1917 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E233-1917?
Check Price and Availability of E233-1917, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E233-1917 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E233-1917
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E233-1917
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E233-1917 available by request